News in Care & Treatment

MBWC's Justin Miller presented the latest on brain health and aging in a webinar hosted by the AARP, alongside other experts. He discussed the distinctions between normal aging, mild cognitive impairment, and dementia. He clarified some of the biggest questions on the minds of community members, such as, What is MCI? And how is MCI different from normal age-related declines?

Read More

Categories: Science Updates, Care & Treatment , News, Brain Health Awareness

“While we don’t know whether donanemab or lecanemab can arrest Alzheimer’s, they do appear to help people with mild cognitive impairment and extend the time they are independent and able to manage their daily lives,” Dr. Grabowski said.

Read More

Categories: New FDA Drug Approvals, Care & Treatment , News

Enjoy the latest issue of Dimensions Magazine! Find inside the latest findings in Alzheimer's and brain health research, a faculty spotlight, and a new conversation game meant to preserve memories and legacy, and so much more.

Read More

Categories: Science Updates, Care & Treatment , Team Spotlights, Community Stories, Caregiving, Resources, Brain Health, News, Dementia-Friendly Community

The Commission is authored by 27 dementia experts, including the UW ADRC’s Eric B. Larson, MD, MPH, who is affiliate professor of medicine in the UW School of Medicine, who has now worked on all three Lancet reports that make recommendations for policy makers and individuals to help reduce dementia risk worldwide. Larson gives us context for the new recommendations and shares how UW research has influenced this report.

Read More

Categories: Science Updates, Care & Treatment , News, Brain Health Awareness

Clinicians designed a program to help manage the burgeoning wave of patients with cognitive deficits. Via UW Medicine

Read More

Categories: Care & Treatment , Resources, News, Programs

Dr. Angela Hanson's lab team reports back on interesting talks about what’s coming soon in diagnosis, treatment, and prevention of Alzheimer’s and other diseases that lead to cognitive impairment and dementia.

Read More

Categories: Science Updates, New FDA Drug Approvals, Care & Treatment , News

Michael Rosenbloom, MD is a behavioral neurologist and the director of clinical trials for the UW Memory and Brain Wellness Center at the UW ADRC

Read More

Categories: New FDA Drug Approvals, Care & Treatment , Team Spotlights, News

The brain’s ability to clear out waste products during deep sleep is important for brain health. “People with untreated sleep-related breathing disorders are losing that chance to fully regenerate their bodies at night,” says Cho. “I feel so bad when I see this happening because this problem can be treated.”

Read More

Categories: Science Updates, Care & Treatment , News

“I would say the role of a speech language pathologist is to untap someone's functional communication abilities and allow them to express themselves in ways that leave them feeling successful,” says speech-language pathologist Jeanne Gallée, PhD, CCC-SLP, a new ADRC co-investigator and trainee in the ADRC Research and Education Component.

Read More

Categories: Science Updates, Care & Treatment , Team Spotlights, Resources, News

On Thurs. September 14, 2023, the UW MBWC hosted a webinar for patients, families, and the wider community regarding the newly approved infusion medication Leqembi (lecanemab) for the treatment of Alzheimer's. You can watch the webinar recording here.

Read More

Categories: Science Updates, New FDA Drug Approvals, Care & Treatment , News